by admin | Nov 12, 2024 | press-releases
Home PRESS RELEASE CG Oncology Reports Third Quarter 2024 Financial Results and Provides Business Updates 💻 DESKTOP AUDIO PLAYER =============================== --> Listen to this article now 0:00 📱 MOBILE AUDIO PLAYER =============================== --> Listen to...
by admin | Nov 11, 2024 | press-releases
Home PRESS RELEASE CG Oncology’s Phase 1b Study in Nature Medicine 💻 DESKTOP AUDIO PLAYER =============================== --> Listen to this article now 0:00 📱 MOBILE AUDIO PLAYER =============================== --> Listen to this article now 0:00 0.5x 0.75x Normal...
by admin | Apr 24, 2024 | press-releases
Home PRESS RELEASE CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024 💻 DESKTOP AUDIO PLAYER =============================== --> Listen to this article now 0:00 📱 MOBILE AUDIO PLAYER...
by admin | Mar 28, 2024 | press-releases
Home PRESS RELEASE CG Oncology to Present Results on Cretostimogene at the AUA 2024 Annual Meeting 💻 DESKTOP AUDIO PLAYER =============================== --> Listen to this article now 0:00 📱 MOBILE AUDIO PLAYER =============================== --> Listen to this...
by admin | Feb 27, 2024 | press-releases
Home PRESS RELEASE CG Oncology Announces First Patient Dosed in PIVOT-006 Phase 3 Clinical Trial of Cretostimogene in Intermediate-risk Non-Muscle Invasive Bladder Cancer 💻 DESKTOP AUDIO PLAYER =============================== --> Listen to this article now 0:00 📱...
by admin | Jan 30, 2024 | press-releases
Home PRESS RELEASE CG Oncology Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares 💻 DESKTOP AUDIO PLAYER =============================== --> Listen to this article now 0:00 📱 MOBILE AUDIO PLAYER...